Global Information
회사소개 | 문의 | 비교리스트

세계의 수면장애 시장 : 장애 유형(수면무호흡증, 불면증, RLS, 기면증), 제품별 - COVID-19의 영향, 지역적 전망, 성장 잠재성, 가격 동향, 시장 점유율, 예측(2021-2027년)

Sleep Disorder Market Size By Disorder Type (Sleep Apnea, Insomnia, Restless Legs Syndrome, Narcolepsy), By Product, COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

리서치사 Global Market Insights Inc.
발행일 2021년 12월 상품코드 1044817
페이지 정보 영문 246 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 5,150 ₩ 6,562,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 9,110,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 11,658,000 Printable PDF (Enterprise User License)


세계의 수면장애 시장 : 장애 유형(수면무호흡증, 불면증, RLS, 기면증), 제품별 - COVID-19의 영향, 지역적 전망, 성장 잠재성, 가격 동향, 시장 점유율, 예측(2021-2027년) Sleep Disorder Market Size By Disorder Type (Sleep Apnea, Insomnia, Restless Legs Syndrome, Narcolepsy), By Product, COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
발행일 : 2021년 12월 페이지 정보 : 영문 246 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

수면장애 시장은 전 세계에서 고령자 인구의 증가로 인해 2027년까지 상당한 규모로 성장할 것으로 예측됩니다.

또한 당뇨병 및 비만 등의 생활습관병이 증가하고 있는 것도 향후 수년간 시장 확대로 연결될 것으로 생각되고 있습니다.

장애 유형별로는 기면증 부문이 예측 기간 중 견고한 성장을 보일 것으로 예측됩니다. 기면증의 진단 수 및 치료 수 증가가 향후 수년간 성장 원동력이 될 것으로 추정되고 있습니다. 또한 제품별로는 진단약 부문이 2027년까지 약 6.9%의 CAGR로 성장하며, 시장 규모를 확대할 것으로 예측됩니다. 수면장애에 대한 의식의 향상이 예측 기간 중 시장의 발전을 지원할 것으로 생각됩니다.

세계의 수면장애 시장을 조사했으며, 시장의 정의와 개요, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 역학 동향, 시장 규모의 추이·예측, 장애 유형·제품·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 조사 방법

제2장 개요

제3장 수면장애 산업 인사이트

  • 산업 세분화
  • 산업 상황
  • 산업에 대한 영향요인
    • 성장요인
    • 잠재적 리스크 & 과제
  • 성장의 가능성
  • COVID-19 : 영향 분석
  • 역학·유병률 상황
  • Porter의 산업 분석
  • 경쟁 구도
  • PESTEL 분석

제4장 수면장애 시장 : 장애 유형별

  • 주요 동향
  • 수면무호흡증
    • 폐쇄성 수면무호흡증
    • 중추성 수면무호흡증
    • 복합성 수면무호흡증
  • 불면증
  • 하지불안증후군(RLS)
  • 기면증
  • 기타

제5장 수면장애 시장 : 제품별

  • 주요 동향
  • 진단
    • 액티그래프 시스템
    • 수면다원검사(PSG) 디바이스
    • 호흡 폴리그래프
    • 수면 스크리닝 디바이스
    • 가정용 수면 테스트
    • 기타
  • 치료
    • 인지 행동 요법
    • 치료 디바이스
    • 약물 요법

제6장 수면장애 시장 : 지역별

  • 주요 동향
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제7장 기업 개요

  • 전략 대시보드
  • Astellas Pharma Inc
  • Cadwell Laboratories Inc.
  • Cardinal Health
  • Compumedics Limited
  • Eisai Co Ltd
  • Evotec AG
  • Ferring International Center SA
  • GlaxoSmithKline plc
  • Heptares Therapeutics Ltd
  • Koninklijke Philips N.V.
  • Natus Medical Incorporated
  • ResMed, Inc.
  • Somnetics International, Inc.
  • Takeda Pharmaceutical Company Limited
  • Teleflex, Inc.
  • Teva Pharmaceutical Industries Ltd
KSA 22.01.20

Data Tables

  • TABLE 1 Sleep disorder market industry 360 degree synopsis, 2016 - 2027
  • TABLE 2 Sleep disorder market size, 2016-2027 (USD Million)
  • TABLE 3 Sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 4 Sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 5 Sleep disorder market size, by region, 2016-2027 (USD Million)
  • TABLE 6 Industry impact forces
  • TABLE 7 Sleep apnea market size, by region, 2016-2027 (USD Million)
  • TABLE 8 Obstructive sleep apnea market size, by region, 2016-2027 (USD Million)
  • TABLE 9 Central sleep apnea market size, by region, 2016-2027 (USD Million)
  • TABLE 10 Complex sleep apnea market size, by region, 2016-2027 (USD Million)
  • TABLE 11 Insomnia market size, by region, 2016-2027 (USD Million)
  • TABLE 12 Restless leg syndrome market size, by region, 2016-2027 (USD Million)
  • TABLE 13 Narcolepsy market size, by region, 2016-2027 (USD Million)
  • TABLE 14 Others market size, by region, 2016-2027 (USD Million)
  • TABLE 15 Diagnostics market by region, 2016-2027 (USD Million)
  • TABLE 16 Actigraphy systems market by region, 2016-2027 (USD Million)
  • TABLE 17 Polysomnography {PSG} device market by region, 2016-2027 (USD Million)
  • TABLE 18 Respiratory polygraph market by region, 2016-2027 (USD Million)
  • TABLE 19 Sleep screening devices market by region, 2016-2027 (USD Million)
  • TABLE 20 Home sleep tests market by region, 2016-2027 (USD Million)
  • TABLE 21 Others market by region, 2016-2027 (USD Million)
  • TABLE 22 Therapeutics market by region, 2016-2027 (USD Million)
  • TABLE 23 Cognitive behavioral therapy market by region, 2016-2027 (USD Million)
  • TABLE 24 Therapeutic devices market by region, 2016-2027 (USD Million)
  • TABLE 25 Airway clearance system market by region, 2016-2027 (USD Million)
  • TABLE 26 Adaptive servo-ventilation market by region, 2016-2027 (USD Million)
  • TABLE 27 Positive airway pressure devices market by region, 2016-2027 (USD Million)
  • TABLE 28 Oral appliances market by region, 2016-2027 (USD Million)
  • TABLE 29 Oxygen devices market by region, 2016-2027 (USD Million)
  • TABLE 30 Others market by region, 2016-2027 (USD Million)
  • TABLE 31 Medication therapy market by region, 2016-2027 (USD Million)
  • TABLE 32 Benzodiazepines market by region, 2016-2027 (USD Million)
  • TABLE 33 Dual orexin receptor antagonists market by region, 2016-2027 (USD Million)
  • TABLE 34 Melatonin receptor agonists market by region, 2016-2027 (USD Million)
  • TABLE 35 Antidepressants market by region, 2016-2027 (USD Million)
  • TABLE 36 Others market by region, 2016-2027 (USD Million)
  • TABLE 37 North America sleep disorder market size, by country, 2016-2027 (USD Million)
  • TABLE 38 North America sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 39 North America sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 40 North America sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 41 North America sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 42 North America sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 43 North America Sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 44 North America sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 45 U.S. sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 46 U.S. sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 47 U.S. sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 48 U.S. sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 49 U.S. sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 50 U.S. sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 51 U.S. sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 52 Canada sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 53 Canada sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 54 Canada sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 55 Canada sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 56 Canada sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 57 Canada sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 58 Canada sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 59 Europe sleep disorder market size, by country, 2016-2027 (USD Million)
  • TABLE 60 Europe sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 61 Europe sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 62 Europe sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 63 Europe sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 64 Europe sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 65 Europe sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 66 Europe sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 67 Germany sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 68 Germany sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 69 Germany sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 70 Germany sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 71 Germany sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 72 Germany sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 73 Germany sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 74 France sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 75 France sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 76 France sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 77 France sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 78 France sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 79 France sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 80 France sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 81 U.K. sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 82 U.K. sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 83 U.K. sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 84 U.K. sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 85 U.K. sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 86 U.K. sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 87 U.K. sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 88 Italy sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 89 Italy sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 90 Italy sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 91 Italy sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 92 Italy sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 93 Italy sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 94 Italy sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 95 Spain sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 96 Spain sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 97 Spain sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 98 Spain sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 99 Spain sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 100 Spain sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 101 Spain sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 102 Asia Pacific sleep disorder market size, by country, 2016-2027 (USD Million)
  • TABLE 103 Asia Pacific sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 104 Asia Pacific sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 105 Asia Pacific sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 106 Asia Pacific sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 107 Asia Pacific sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 108 Asia Pacific sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 109 Asia Pacific sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 110 China sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 111 China sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 112 China sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 113 China sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 114 China sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 115 China sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 116 China sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 117 Japan sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 118 Japan sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 119 Japan sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 120 Japan sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 121 Japan sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 122 Japan sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 123 Japan sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 124 India sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 125 India sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 126 India sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 127 India sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 128 India sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 129 India sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 130 India sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 131 South Korea sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 132 South Korea sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 133 South Korea sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 134 South Korea sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 135 South Korea sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 136 South Korea sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 137 South Korea sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 138 Australia sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 139 Australia sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 140 Australia sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 141 Australia sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 142 Australia sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 143 Australia sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 144 Australia sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 145 New Zealand sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 146 New Zealand sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 147 New Zealand sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 148 New Zealand sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 149 New Zealand sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 150 New Zealand sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 151 New Zealand sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 152 Latin America sleep disorder market size, by country, 2016-2027 (USD Million)
  • TABLE 153 Latin America sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 154 Latin America sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 155 Latin America sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 156 Latin America sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 157 Latin America sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 158 Latin America sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 159 Latin America sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 160 Brazil sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 161 Brazil sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 162 Brazil sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 163 Brazil sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 164 Brazil sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 165 Brazil sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 166 Brazil sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 167 Mexico sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 168 Mexico sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 169 Mexico sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 170 Mexico sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 171 Mexico sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 172 Mexico sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 173 Mexico sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 174 Argentina sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 175 Argentina sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 176 Argentina sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 177 Argentina sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 178 Argentina sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 179 Argentina sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 180 Argentina sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 181 MEA sleep disorder market size, by country, 2016-2027 (USD Million)
  • TABLE 182 MEA sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 183 MEA sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 184 MEA sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 185 MEA sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 186 MEA sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 187 MEA sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 188 MEA sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 189 Saudi Arabia sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 190 Saudi Arabia sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 191 Saudi Arabia sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 192 Saudi Arabia sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 193 Saudi Arabia sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 194 Saudi Arabia sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 195 Saudi Arabia sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 196 UAE sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 197 UAE sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 198 UAE sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 199 UAE sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 200 UAE sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 201 UAE sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 202 UAE sleep disorder market size, by medication therapy, 2016-2027 (USD Million)
  • TABLE 203 South Africa sleep disorder market size, by disorder type, 2016-2027 (USD Million)
  • TABLE 204 South Africa sleep disorder market size, by sleep apnea, 2016-2027 (USD Million)
  • TABLE 205 South Africa sleep disorder market size, by product, 2016-2027 (USD Million)
  • TABLE 206 South Africa sleep disorder market size, by diagnostics, 2016-2027 (USD Million)
  • TABLE 207 South Africa sleep disorder market size, by therapeutics, 2016-2027 (USD Million)
  • TABLE 208 South Africa sleep disorder market size, by therapeutic devices, 2016-2027 (USD Million)
  • TABLE 209 South Africa sleep disorder market size, by medication therapy, 2016-2027 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global sleep disorder market size, 2016 - 2027 (USD Million)
  • FIG. 3 Growth potential analysis, by disorder type
  • FIG. 4 Growth potential analysis, by product
  • FIG. 5 Porter's analysis
  • FIG. 6 Competitive matrix analysis, 2020
  • FIG. 7 PESTEL analysis
  • FIG. 8 Key segment trends, by disorder type
  • FIG. 9 Key segment trends, by product
  • FIG. 10 Key regional trends
  • FIG. 11 Strategy dashboard, 2020

The sleep disorder market is speculated to attain a substantial valuation by 2027 owing to growing geriatric population around the world. In addition, increasing incidences of several lifestyle diseases like diabetes and obesity are set to augment industry uptake over the forthcoming years.

According to a 2021 study published by Elsevier Public Health Emergency Collection, the Covid-19 pandemic has been shown to cause various sleep dysfunctions, including disrupted circadian rhythm, insomnia, and decreased sleep quality among the affected as well as the general population. The mounting prevalence of sleep disorders caused due to the outbreak has prompted healthcare companies to undertake extensive R&D activities, which has boosted market growth in recent years.

Notably, industry participants have been implementing lucrative initiatives to gain a competitive edge in the evolving marketplaces, which has positively impacted the overall business scenario. For instance, in June 2021, Cadwell Industries, Inc., a major provider of neuromonitoring and neurodiagnostic solutions, inked a partnership with EnsoData, a leading healthcare AI company.

According to the deal, Cadwell has integrated EnsoData's EnsoSleep AI solution to its Easy III PSG software platform, which is intended to significantly reduce the burden of manual analysis on sleep clinicians, thereby giving them more time to focus on the treatment procedures.

To cite another instance, in December 2019, Eisai, Co., Ltd., received the U.S. Food and Drug Administration (FDA) approval for its novel orexin receptor antagonist, dubbed DAYVIGOTM (Lemborexant). The latest lemborexant drug has been approved for the treatment of insomnia in adults, which is characterized by problems with sleep maintenance or sleep onset.

The sleep disorder market has been segregated on the basis of product, disorder type, and region.

With respect to disorder type, the market has further been bifurcated into narcolepsy, sleep apnea, restless legs syndrome, insomnia, and others.

The narcolepsy sub-segment accounted for a market share of nearly 8% in 2020 and is projected to grow at a solid pace over the forecast timeline. Increase in the number of diagnoses and treatments for narcolepsy is estimated to drive segmental expansion over the forthcoming years.

In terms of product, the sleep disorder market has been categorized into therapeutics and diagnostics. The diagnostics sub-segment is speculated to attain a substantial valuation by 2027, expanding at a CAGR of approximately 6.9% over the assessment period. Growing awareness regarding sleep disorders would escalate the demand for sleep disorder diagnostics, which is likely to support market development over the analysis timeframe.

From the regional point of view, the Latin America sleep disorder market registered a market size of over USD 657.9 million in 2020 and is slated to showcase a robust growth trajectory through the study period. This growth is attributed to the rising prevalence of sleep disorders across the region.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Sleep disorder industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Disorder type trends
    • 2.1.3 Product trends
    • 2.1.4 Regional trends

Chapter 3 Sleep Disorder Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Surging prevalence of sleeping disorders throughout the world
      • 3.3.1.2 Increasing awareness regarding the sleep disorders
      • 3.3.1.3 Rising elderly population globally
      • 3.3.1.4 Product innovation and adoption of different strategies by key market participants
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Stringent regulatory framework
      • 3.3.2.2 High cost of sleep devices
  • 3.4 Growth potential analysis
    • 3.4.1 By disorder type
    • 3.4.2 By product
  • 3.5 COVID-19 impact analysis
  • 3.6 Epidemiology and prevalence landscape
    • 3.6.1 Obstructive sleep apnea (OSA)
    • 3.6.2 Insomnia
    • 3.6.3 Restless leg syndrome (RLS)
    • 3.6.4 Narcolepsy
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2020
    • 3.8.1 Competitive matrix analysis, 2020
  • 3.9 PESTEL analysis

Chapter 4 Sleep Disorder Market, By Disorder Type

  • 4.1 Key segment trends
  • 4.2 Sleep apnea
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.2 Obstructive sleep apnea
      • 4.2.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.3 Central sleep apnea
      • 4.2.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.4 Complex sleep apnea
      • 4.2.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Insomnia
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Restless legs syndrome (RLS)
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Narcolepsy
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.6 Others
    • 4.6.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Sleep Disorder Market, By Product

  • 5.1 Key segment trends
  • 5.2 Diagnostics
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.2 Actigraphy systems
      • 5.2.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.3 Polysomnography (PSG) device
      • 5.2.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.4 Respiratory polygraph
      • 5.2.4.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.5 Sleep screening devices
      • 5.2.5.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.6 Home sleep tests
      • 5.2.6.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.2.7 Others
      • 5.2.7.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Therapeutics
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.3.2 Cognitive behavioral therapy
      • 5.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.3.3 Therapeutic devices
      • 5.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.3.2 Airway clearance system
        • 5.3.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.3.3 Adaptive servo-ventilation (ASV)
        • 5.3.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.3.4 Positive airway pressure (PAP) devices
        • 5.3.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.3.5 Oral appliances
        • 5.3.3.5.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.3.6 Oxygen devices
        • 5.3.3.6.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.3.7 Others
        • 5.3.3.7.1 Market size, by region, 2016 - 2027 (USD Million)
    • 5.3.4 Medication therapy
      • 5.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.4.2 Benzodiazepines
        • 5.3.4.2.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.4.3 Dual orexin receptor antagonists
        • 5.3.4.3.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.4.4 Melatonin receptor agonists
        • 5.3.4.4.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.4.5 Antidepressants
        • 5.3.4.5.1 Market size, by region, 2016 - 2027 (USD Million)
      • 5.3.4.6 Others
        • 5.3.4.6.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Sleep Disorder Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country 2016 - 2027 (USD Million)
    • 6.2.2 Market size, by disorder type, 2016 - 2027 (USD Million)
      • 6.2.2.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
    • 6.2.3 Market size, by product, 2016-2027 (USD Million)
      • 6.2.3.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
      • 6.2.3.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.2.3.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.2.3.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.2.4.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.2.4.2 Market size, by product, 2016-2027 (USD Million)
        • 6.2.4.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.2.4.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.2.4.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.2.4.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.2.5.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.2.5.2 Market size, by product, 2016-2027 (USD Million)
        • 6.2.5.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.2.5.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.2.5.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.2.5.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country 2016 - 2027 (USD Million)
    • 6.3.2 Market size, by disorder type, 2016 - 2027 (USD Million)
      • 6.3.2.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
    • 6.3.3 Market size, by product, 2016-2027 (USD Million)
      • 6.3.3.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
      • 6.3.3.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.3.3.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.3.3.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.3.4.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.3.4.2 Market size, by product, 2016-2027 (USD Million)
        • 6.3.4.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.3.4.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.3.4.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.3.4.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.3.5 France
      • 6.3.5.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.3.5.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.3.5.2 Market size, by product, 2016-2027 (USD Million)
        • 6.3.5.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.3.5.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.3.5.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.3.5.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.3.6 UK
      • 6.3.6.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.3.6.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.3.6.2 Market size, by product, 2016-2027 (USD Million)
        • 6.3.6.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.3.6.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.3.6.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.3.6.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.3.7 Italy
      • 6.3.7.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.3.7.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.3.7.2 Market size, by product, 2016-2027 (USD Million)
        • 6.3.7.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.3.7.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.3.7.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.3.7.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.3.8 Spain
      • 6.3.8.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.3.8.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.3.8.2 Market size, by product, 2016-2027 (USD Million)
        • 6.3.8.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.3.8.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.3.8.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.3.8.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country 2016 - 2027
    • 6.4.2 Market size, by disorder type, 2016 - 2027 (USD Million)
      • 6.4.2.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
    • 6.4.3 Market size, by product, 2016-2027 (USD Million)
      • 6.4.3.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
      • 6.4.3.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.4.3.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.4.3.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.4.4 China
      • 6.4.4.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.4.4.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.4.4.2 Market size, by product, 2016-2027 (USD Million)
        • 6.4.4.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.4.4.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.4.4.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.4.4.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.4.5 Japan
      • 6.4.5.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.4.5.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.4.5.2 Market size, by product, 2016-2027 (USD Million)
        • 6.4.5.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.4.5.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.4.5.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.4.5.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.4.6.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.4.6.2 Market size, by product, 2016-2027 (USD Million)
        • 6.4.6.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.4.6.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.4.6.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.4.6.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.4.7 South Korea
      • 6.4.7.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.4.7.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.4.7.2 Market size, by product, 2016-2027 (USD Million)
        • 6.4.7.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.4.7.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.4.7.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.4.7.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.4.8 Australia
      • 6.4.8.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.4.8.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.4.8.2 Market size, by product, 2016-2027 (USD Million)
        • 6.4.8.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.4.8.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.4.8.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.4.8.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.4.9 New Zealand
      • 6.4.9.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.4.9.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.4.9.2 Market size, by product, 2016-2027 (USD Million)
        • 6.4.9.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.4.9.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.4.9.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.4.9.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country 2016 - 2027
    • 6.5.2 Market size, by disorder type, 2016 - 2027 (USD Million)
      • 6.5.2.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
    • 6.5.3 Market size, by product, 2016-2027 (USD Million)
      • 6.5.3.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
      • 6.5.3.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.5.3.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.5.3.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.5.4.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.5.4.2 Market size, by product, 2016-2027 (USD Million)
        • 6.5.4.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.5.4.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.5.4.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.5.4.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.5.5.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.5.5.2 Market size, by product, 2016-2027 (USD Million)
        • 6.5.5.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.5.5.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.5.5.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.5.5.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.5.6 Argentina
      • 6.5.6.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.5.6.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.5.6.2 Market size, by product, 2016-2027 (USD Million)
        • 6.5.6.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.5.6.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.5.6.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.5.6.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
  • 6.6 Middle East and Africa
    • 6.6.1 Market size, by country 2016 - 2027
    • 6.6.2 Market size, by disorder type, 2016 - 2027 (USD Million)
      • 6.6.2.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
    • 6.6.3 Market size, by product, 2016-2027 (USD Million)
      • 6.6.3.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
      • 6.6.3.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.6.3.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.6.3.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.6.4.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.6.4.2 Market size, by product, 2016-2027 (USD Million)
        • 6.6.4.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.6.4.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.6.4.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.6.4.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.6.5 South Africa
      • 6.6.5.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.6.5.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.6.5.2 Market size, by product, 2016-2027 (USD Million)
        • 6.6.5.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.6.5.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.6.5.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.6.5.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)
    • 6.6.6 Saudi Arabia
      • 6.6.6.1 Market size, by disorder type, 2016 - 2027 (USD Million)
        • 6.6.6.1.1 Market size, by Sleep apnea, 2016-2027 (USD Million)
      • 6.6.6.2 Market size, by product, 2016-2027 (USD Million)
        • 6.6.6.2.1 Market size, by diagnostics, 2016 - 2027 (USD Million)
        • 6.6.6.2.2 Market size, by therapeutics, 2016 - 2027 (USD Million)
        • 6.6.6.2.2.1 Market size, by therapeutic devices, 2016-2027 (USD Million)
        • 6.6.6.2.2.2 Market size, by medication therapy, 2016-2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Strategy dashboard, 2020
  • 7.2 Astellas Pharma Inc
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 Cadwell Laboratories Inc.
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Cardinal Health
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 Compumedics Limited
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 Eisai Co Ltd
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Evotec AG
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Ferring International Center SA
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 GlaxoSmithKline plc
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Heptares Therapeutics Ltd
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 Koninklijke Philips N.V.
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis
  • 7.12 Natus Medical Incorporated
    • 7.12.1 Business overview
    • 7.12.2 Financial data
    • 7.12.3 Product landscape
    • 7.12.4 Strategic outlook
    • 7.12.5 SWOT analysis
  • 7.13 ResMed, Inc.
    • 7.13.1 Business overview
    • 7.13.2 Financial data
    • 7.13.3 Product landscape
    • 7.13.4 Strategic outlook
    • 7.13.5 SWOT analysis
  • 7.14 Somnetics International, Inc.
    • 7.14.1 Business overview
    • 7.14.2 Financial data
    • 7.14.3 Product landscape
    • 7.14.4 Strategic outlook
    • 7.14.5 SWOT analysis
  • 7.15 Takeda Pharmaceutical Company Limited
    • 7.15.1 Business overview
    • 7.15.2 Financial data
    • 7.15.3 Product landscape
    • 7.15.4 Strategic outlook
    • 7.15.5 SWOT analysis
  • 7.16 Teleflex, Inc.
    • 7.16.1 Business overview
    • 7.16.2 Financial data
    • 7.16.3 Product landscape
    • 7.16.4 Strategic outlook
    • 7.16.5 SWOT analysis
  • 7.17 Teva Pharmaceutical Industries Ltd
    • 7.17.1 Business overview
    • 7.17.2 Financial data
    • 7.17.3 Product landscape
    • 7.17.4 Strategic outlook
    • 7.17.5 SWOT analysis
Back to Top
전화 문의
F A Q